EU-GMP Authorities Conclude Inspection of Concord Biotech's Unit in Limbassi, India; Shares Up 3%

MT Newswires Live

2025/08/21

Concord Biotech (NSE:CONCORDBIO, BOM:543960) said the European Union Good Manufacturing Practice (EU-GMP) authorities have completed the first inspection of the company's active pharmaceutical ingredients (API) manufacturing facility in Limbassi, India, according to a Thursday filing to the Indian stock exchanges.

The inspection was carried out from Aug. 18 to Aug. 21.

The approval will help Concord to look at commercial opportunities across various territories in the European Union and other regulated geographies.

The company's shares were up over 3% in recent trade.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2561446377"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2561446377\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2561446377?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-21 17:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2561446377","market":"nz","top_or_hot":-1,"title":"EU-GMP Authorities Conclude Inspection of Concord Biotech's Unit in Limbassi, India; Shares Up 3%","media":"MT Newswires Live","content":"<html><body><p> Concord Biotech (NSE:CONCORDBIO, BOM:543960) said the European Union Good Manufacturing Practice (EU-GMP) authorities have completed the first inspection of the company's active pharmaceutical ingredients (API) manufacturing facility in Limbassi, India, according to a Thursday filing to the Indian stock exchanges.</p><p>The inspection was carried out from Aug. 18 to Aug. 21.</p><p>The approval will help Concord to look at commercial opportunities across various territories in the European Union and other regulated geographies.</p><p>The company's shares were up over 3% in recent trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU-GMP Authorities Conclude Inspection of Concord Biotech's Unit in Limbassi, India; Shares Up 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU-GMP Authorities Conclude Inspection of Concord Biotech's Unit in Limbassi, India; Shares Up 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-21 17:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Concord Biotech (NSE:CONCORDBIO, BOM:543960) said the European Union Good Manufacturing Practice (EU-GMP) authorities have completed the first inspection of the company's active pharmaceutical ingredients (API) manufacturing facility in Limbassi, India, according to a Thursday filing to the Indian stock exchanges.</p><p>The inspection was carried out from Aug. 18 to Aug. 21.</p><p>The approval will help Concord to look at commercial opportunities across various territories in the European Union and other regulated geographies.</p><p>The company's shares were up over 3% in recent trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4156","symbol_name":"煤与消费用燃料","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2561446377","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2561446377","pubTimestamp":1755769443,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Concord Biotech  said the European Union Good Manufacturing Practice  authorities have completed the first inspection of the company's active pharmaceutical ingredients  manufacturing facility in Limbassi, India, according to a Thursday filing to the Indian stock exchanges.The inspection was carried out from Aug. 18 to Aug. 21.The approval will help Concord to look at commercial opportunities across various territories in the European Union and other regulated geographies.The company's shares were up over 3% in recent trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4156":"煤与消费用燃料","BK7103":"保健护理产品经销商","API.AU":"Australian Pharma Industries","API":"声网","BK4023":"应用软件","BK4535":"淡马锡持仓","BK4503":"景林资产持仓","CNDA":"Concord Acquisition Corp II","BK4551":"寇图资本持仓"},"translate_title":"EU-GMP当局结束对Concord Biotech位于印度林巴西的工厂的检查；股价上涨3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"API.AU":1,"MNDmain":1,"CNDA":1,"API":1},"content_text":"Concord Biotech (NSE:CONCORDBIO, BOM:543960) said the European Union Good Manufacturing Practice (EU-GMP) authorities have completed the first inspection of the company's active pharmaceutical ingredients (API) manufacturing facility in Limbassi, India, according to a Thursday filing to the Indian stock exchanges.The inspection was carried out from Aug. 18 to Aug. 21.The approval will help Concord to look at commercial opportunities across various territories in the European Union and other regulated geographies.The company's shares were up over 3% in recent trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}